Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$37.44 - $46.51 $56,422 - $70,090
1,507 Added 25.28%
7,469 $331,000
Q3 2022

Nov 10, 2022

BUY
$42.27 - $57.6 $252,013 - $343,411
5,962 New
5,962 $254,000
Q3 2021

Oct 07, 2021

SELL
$52.17 - $70.2 $701,634 - $944,119
-13,449 Closed
0 $0
Q2 2021

Aug 04, 2021

SELL
$68.86 - $83.34 $788,033 - $953,742
-11,444 Reduced 45.97%
13,449 $927,000
Q1 2021

May 04, 2021

SELL
$76.15 - $111.94 $693,421 - $1.02 Million
-9,106 Reduced 26.78%
24,893 $1.92 Million
Q4 2020

Feb 02, 2021

SELL
$96.85 - $148.25 $377,037 - $577,137
-3,893 Reduced 10.27%
33,999 $3.37 Million
Q3 2020

Oct 09, 2020

SELL
$122.47 - $213.56 $873,700 - $1.52 Million
-7,134 Reduced 15.84%
37,892 $5.38 Million
Q2 2020

Jul 08, 2020

BUY
$185.52 - $231.25 $598,487 - $746,012
3,226 Added 7.72%
45,026 $8.88 Million
Q1 2020

Apr 23, 2020

BUY
$143.0 - $274.03 $3.75 Million - $7.19 Million
26,234 Added 168.53%
41,800 $8.19 Million
Q4 2019

Feb 11, 2020

BUY
$146.12 - $215.82 $134,430 - $198,554
920 Added 6.28%
15,566 $3.22 Million
Q3 2019

Oct 17, 2019

BUY
$130.44 - $187.64 $175,833 - $252,938
1,348 Added 10.14%
14,646 $2.24 Million
Q2 2019

Aug 02, 2019

SELL
$111.45 - $128.93 $56,170 - $64,980
-504 Reduced 3.65%
13,298 $1.72 Million
Q1 2019

May 10, 2019

BUY
$89.61 - $117.78 $38,801 - $50,998
433 Added 3.24%
13,802 $1.63 Million
Q4 2018

Feb 13, 2019

BUY
$87.81 - $110.65 $1.17 Million - $1.48 Million
13,369 New
13,369 $1.23 Million
Q3 2018

Nov 14, 2018

SELL
$90.63 - $120.22 $165,581 - $219,641
-1,827 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$94.51 - $120.23 $46,120 - $58,672
-488 Reduced 21.08%
1,827 $182,000
Q4 2017

Feb 20, 2018

BUY
$84.48 - $104.02 $48,407 - $59,603
573 Added 32.89%
2,315 $217,000
Q3 2017

Nov 13, 2017

BUY
$73.17 - $103.47 $77,779 - $109,988
1,063 Added 156.55%
1,742 $177,000
Q2 2017

Aug 14, 2017

BUY
N/A
679
679 $52,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.9B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.